Table 1.
Demographical clinical characteristics of all study participants.
Value for groupa |
||||
---|---|---|---|---|
HIV- | HIV+, IRs | HIV+, INRs | p value (two HIV+ groups)c | |
Number of participants | 60 | 31 | 40 | |
Sex (Male/Female) | 42/18 | 23/8 | 39/1 | |
Age (yr) | 37.5 | 46 | 52 | 0.0011 |
(31-55.75) | (35-53) | (45.25-60.75) | ||
Race (AA/W/Others)b | 15/38/7 | 17/14/0 | 4/30/2006 | NA |
CD4+ T cell counts (Cells/μl) | 707 | 253 | <0.0001 | |
(545-958) | (212.5-310.8) | |||
Nadir CD4+ T cell counts | 207 | 59.5 | <0.0001 | |
(50-353) | (23-128.8) | |||
Viral load pre-ARTd | 37300 | 57307 | 0.78 | |
(31336-119535) | (48816-60202) | |||
Time from diagnosis to ART (year)d | 7 | 10 | 0.196 | |
(4-12) | (6-14) | |||
Duration of ARTd | 5 | 7.5 | 0.0006 | |
(4-6) | (5-9.75) | |||
Duration of undetectable virusd | 4 | 7 | 0.0023 | |
(3-6) | (4-8) | |||
Viral blipsd | 1 | 1 | 0.4 | |
(0-4) | (0-2) |
Data are medians (interquartile ranges).
AA: African American; W: White; Others: Mixed Ethnicity/Multiracial and Hispanic/Latino.
Fisher's exact test or Mann-Whitney's U test (unpaired) were used.
Descriptive statistics have removed unknown or unavailable data (NA), details see Supplementary Table 1.